The markets retreated from earlier highs but still closed modestly high with the Dow rising 33 points to 17,548 as investors welcomed a rally in the Chinese markets and a potential Greek reform plan. Nasdaq gained 12 points to 4,992.

On the upside

The Food and Drug Administration rescinded its previous requirement that IntelliPharmaCeutics International (Nasdaq: IPCI) meet additional guidelines before approval of the company’s generic version of Focalin XR(R).

A rebound in the Chinese stock market lifted shares of China Ming Yang Wind Power (NYSE: MY).
 
Shares of Enzon Pharmaceuticals (Nasdaq: ENZN) extended its gains.
 
On the downside

Shares of TrueCar (Nasdaq: TRUE) continued falling.

Investors locked in profits on SciClone Pharmaceuticals (Nasdaq: SCLN).

Super Micro Computer (Nasdaq: SMCI) expanded its support for Intel SSD Data Center Family but the stock price dropped.

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 added 4 points to 2051. Bitcoin added $3 to $268.